NCT07062393

Effect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery

Completed NA Last updated 17 July 2025

What this trial tests

NA trial testing Traditional Counseling → MAR Counseling in Lung Cancer Patients in 47 participants. Completed in 19 June 2023.

Timeline

15 July 2022

Primary endpoint
19 June 2023

19 June 2023

Quick facts

Lead sponsor	Tri-Service General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	health services research
Enrollment	47
Start date	15 July 2022
Primary completion	19 June 2023
Estimated completion	19 June 2023
Sites	1 location across Taiwan

Drugs / interventions tested

• Traditional Counseling → MAR Counseling
• MAR Counseling → Traditional Counseling

Conditions studied

• Lung Cancer Patients — all drugs for Lung Cancer Patients →

Sponsor

Tri-Service General Hospital

Who can join

Adults 20 to 65, any sex, with Lung Cancer Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial evaluates the effectiveness of Mobile Augmented Reality (MAR) counseling compared to traditional verbal counseling for patients undergoing thoracic surgery. MAR counseling integrates patient-specific 3D anatomical models to enhance understanding of surgical procedures and risks. The study assesses patient and caregiver satisfaction, decision-making confidence, and communication quality. Health care providers' perspectives on the counseling methods are also examined. Participants will be assigned to one of the two counseling groups and asked to complete a questionnaire immediately after the counseling session.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery: Randomized Clinical Crossover Trial.
   Chen YS, Hsu YC, Romalee W, Wang DH, et al · · 2025 · PMID 41069141 · DOI 10.2196/79632